Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0371-01
Published July 11, 2012 · Recall initiated: April 17, 2012
Summary
FDA records drug Class III recall D-1401-2012, published July 11, 2012 and initiated April 17, 2012. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 21,572 bottles; Lot: Lot #s: 101696A, 110829A, 123685A, 123687A. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
What to do
Voluntary: Firm initiated · Letter
Get an email if LOXAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LOXAPINE
- Manufacturer
- Watson Laboratories Inc
- Distributor
- Nationwide.
- UPC
- 0305910369019
- Lot
- Lot #s: 101696A, 110829A, 123685A, 123687A
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALoxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CAJuly 11, 2012
- FDALoxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CAJuly 11, 2012
- FDALoxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CAJuly 11, 2012
- FDALoxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson LaboratoriesJuly 11, 2012
- FDAImodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons,July 11, 2012
- FDAARCHITECT CA 19-9XR Reagent Kit; ARCHITECT CA 19-9 Reagent Kit, list 291-20 (4 x 100 tests), 2K91-25 andJuly 4, 2012
Questions about this recall
Was Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC # 0591-0371-01 recalled?
Yes. FDA published recall D-1401-2012 on July 11, 2012. Reported hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LOXAPINE. UPC: 0305910369019.